Citation Impact
Citing Papers
Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence
2006 Standout
Dual Angiotensin Receptor and Neprilysin Inhibition as an Alternative to Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale for and Design of the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure Trial (PARADIGM-HF)
2013
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
EglN2 associates with the NRF 1‐ PGC 1α complex and controls mitochondrial function in breast cancer
2015 StandoutNobel
Baseline Characteristics and Treatment of Patients in Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF)
2014
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study
1999
Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides
2005
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
2008 Standout
Clinical criteria and biochemical markers for the detection of systolic dysfunction
2000
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2010 Standout
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Guidelines for the diagnosis and treatment of chronic heart failure
2001
Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure
2004 StandoutNobel
Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction
2006
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
2003 Standout
Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure
2006
N‐terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
2003
Drug penetration in solid tumours
2006 Standout
Plasma Homocysteine and Risk for Congestive Heart Failure in Adults Without Prior Myocardial Infarction
2003
Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction
2002
Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction
2001
Acute Cardiac Tamponade
2003 Standout
Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload
2001
Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure
2004
Cardiac autophagy is a maladaptive response to hemodynamic stress
2007 Standout
ABC of heart failure: History and epidemiology
2000
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Plasma brain natriuretic peptide concentration: impact of age and gender
2002
Control of lipolysis by natriuretic peptides and cyclic GMP
2008
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
Exploiting tumour hypoxia in cancer treatment
2004 Standout
RNAi screening for fat regulatory genes with SRS microscopy
2011 StandoutNobel
Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: Results from the Dallas Heart Study
2009
Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction
2004
Hormones and Hemodynamics in Heart Failure
1999
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Prevention of Heart Failure
2008
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
2003 Standout
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Natriuretic Peptides
2007
The Impact of Cardiac Natriuretic Peptide Determination on the Diagnosis and Management of Heart Failure
2001
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE>
2007 Standout
Plasma B-type natriuretic peptide levels in systolic heart failure
2004
Impact of age and sex on plasma natriuretic peptide levels in healthy adults
2002
The use of B‐type natriuretic peptide in the management of elderly patients with acute dyspnoea
2005
Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
2017 Standout
Is the prognosis of heart failure improving?
2000
Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure
1998
Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism
2006
Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction
2001
Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea
2004
Negative Regulation of Hypoxic Responses via Induced Reptin Methylation
2010 StandoutNobel
Cognitive and Behavioral Outcomes of School-Aged Children Who Were Born Preterm
2002 Standout
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy
2004
Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting
2001
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
2005 Standout
Combined utility of brain natriuretic peptide and cardiac troponine T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism
2006
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial
2004 Standout
Biomarkers in Heart Failure
2008 Standout
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
2003 Standout
The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis
2003
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
N‐terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF)
2004
More ‘malignant’ than cancer? Five‐year survival following a first admission for heart failure
2001
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure
2002
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction
2002
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Effect of bariatric surgery on heart failure
2017
Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening
2013
Advanced Glycation End Products
2006 Standout
Measurement and significance of circulating natriuretic peptides in cardiovascular disease
1998
The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe Part 2: treatment
2003
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
A Breaker of Advanced Glycation End Products Attenuates Diabetes-Induced Myocardial Structural Changes
2003
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
2004
Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
2006 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Oxidative Stress and Diabetic Complications
2010 Standout
Natural History of Asymptomatic Left Ventricular Systolic Dysfunction in the Community
2003
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
N-Terminal Pro–Brain Natriuretic Peptide or Troponin Testing Followed by Echocardiography for Risk Stratification of Acute Pulmonary Embolism
2005
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
Novel markers for heart failure diagnosis and prognosis
2005
Mechanisms of Diabetic Complications
2013 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Increased Brain Natriuretic Peptide as a Marker for Right Ventricular Dysfunction in Acute Pulmonary Embolism
2001
National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008
2011
Angiotensin Receptor Blockade and Exercise Capacity in Adults With Systemic Right Ventricles
2005
Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure
2002
A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010
2015
Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration
2002 StandoutNobel
Works of T. McDonagh being referenced
Candoxatril improves exercise capacity in patients with chronic heart failure receiving angiotensin converting enzyme inhibition
1998
Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK
2009
Biochemical detection of left-ventricular systolic dysfunction
1998
Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure?
1998